Development Level

Tbio 4 | 10,625

IMPC Term

embryonic lethality prior to t... 1 | 187
preweaning lethality, complete... 1 | 633

Disease

group 3 medulloblastoma 3 | 2,254
Kallmann Syndrome 2 | 33
Klinefelter's syndrome 2 | 59
oligodendroglioma 2 | 2,849
ovarian cancer 2 | 8,484
22q11 Deletion Syndrome 1 | 7
Achondroplasia 1 | 20
Alobar Holoprosencephaly 1 | 14
Brain disease 1 | 83
Breast cancer 1 | 3,094
CHARGE syndrome 1 | 23
Cancer 1 | 2,346
Cardiovascular Abnormalities 1 | 7
Cartilage Diseases 1 | 5
Cleft Lip 1 | 91
Cleft palate 1 | 125
Craniofacial Abnormalities 1 | 147
Craniosynostosis 1 | 47
DiGeorge syndrome 1 | 46
Diaphragmatic Hernia 1 | 40
Duane Retraction Syndrome 1 | 9
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA 1 | 1
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA 1 | 1
Holoprosencephaly 1 | 52
Hypogonadism 1 | 70
Hypospadias 1 | 65
Kallmann Syndrome 6 1 | 1
LADD syndrome 1 | 9
Lobar Holoprosencephaly 1 | 14
Machado-Joseph disease 1 | 18
Neurodegenerative disease 1 | 383
Opitz-GBBB syndrome 1 | 19
Osteoarthritis 1 | 96
Osteoporosis 1 | 257
Parkinson's disease 1 | 364
Polycystic Ovary Syndrome 1 | 332
Polydactyly 1 | 93
Renal agenesis 1 | 25
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR 1 | 14
SPINOCEREBELLAR ATAXIA 27 1 | 1
Semilobar Holoprosencephaly 1 | 14
Spinocerebellar ataxia type 27 1 | 1
Spinocerebellar ataxia type 28 1 | 2
Synostosis 1 | 18
Velocardiofacial syndrome 1 | 45
Venous Thromboembolism 1 | 34
adult high grade glioma 1 | 2,148
astrocytic glioma 1 | 2,241
atypical teratoid / rhabdoid tumor 1 | 4,369
chronic rhinosinusitis 1 | 512
cystic fibrosis and chronic rhinosinusitis 1 | 213
dentatorubral-pallidoluysian atrophy 1 | 21
ependymoma 1 | 2,514
glioblastoma 1 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
malignant mesothelioma 1 | 3,162
medulloblastoma, large-cell 1 | 6,234
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
osteosarcoma 1 | 7,933
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
pre-eclampsia 1 | 67
primitive neuroectodermal tumor 1 | 3,031
psoriasis 1 | 6,685
subependymal giant cell astrocytoma 1 | 2,287
type II diabetes mellitus and post-ischemic heart failure 1 | 89

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971

Grant Application

5R01CA060673-08 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fibroblast growth factor 18 FGF18 Tbio Non-IDG -1.83412 76.6 133
Fibroblast growth factor 14 FGF14 Tbio Non-IDG -1.50393 39.1 107
Fibroblast growth factor 17 FGF17 Tbio Non-IDG -1.54736 35.2 131
Fibroblast growth factor 8 FGF8 Tbio Non-IDG -2.70893 513.2 251